학술논문
Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials
Document Type
Article
Author
Source
In ESMO Open December 2022 7(6)
Subject
Language
ISSN
2059-7029